An interventional study of Control Group and Intervention Group in Type 2 Diabetes Mellitus(T2DM), sponsored by Universiti Malaysia Sabah. Not yet recruiting at 1 site in Malaysia. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-09-19.
Sponsored by Universiti Malaysia Sabah · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 170 studies in Diabetes Mellitus, Type 2 with a site in Malaysia — 19 open to participants now, 19 under way, 6 of them phase 3. Diabetes Mellitus, Type 2 · Malaysia.
Among the 170 studies in Diabetes Mellitus, Type 2 with a site in Malaysia, this one is the 124th largest by planned enrollment of the 149 interventional ones that give a count, is one of 9 that started in 2025, is one of 39 with no phase, reaches primary completion later than 2 of the 18 other live ones, and was the 148th registered.
10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.
Browse Diabetes Mellitus, Type 2 studies →19 of the 170 studies in Diabetes Mellitus, Type 2 with a site in Malaysia are open now. Recruiting first, the newest first:
AstraZeneca · Sites in Malaysia, China, Hong Kong and 2 more countries
Ages 18+
Novo Nordisk A/S · Sites in Malaysia, United States, Argentina and 7 more countries
Ages 10–18
AstraZeneca · Sites in Malaysia, United States, Australia and 10 more countries
Ages 18+
AstraZeneca · Sites in Malaysia, United States, Argentina and 21 more countries
Ages 18+
AstraZeneca · Sites in Malaysia, United States, Bulgaria and 13 more countries
Ages 18+
A study can be open while its sites in Malaysia have not opened yet or have stopped. Only those recruiting at a site in Malaysia →
Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
170 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 8 · Phase 3 86 · Phase 4 16
First in 2001; this study’s year is marked. 9 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 62 is below the median of 80 across 8,372 interventional studies indexed under Diabetes Mellitus, Type 2.
Median enrollment 370 across the 149 interventional studies, 1,122 across the 21 observational. Of the 141 that completed or were terminated, 68 (48%) have results posted.
This tab as a report to print or save as PDF → With an account.
117 of 170 have an industry lead sponsor. The 10 most frequent:
Universiti Malaysia Sabah is the lead sponsor of 5 studies on the registry; 3 are open to participants now.
Universiti Malaysia Sabah has 1 study filed under Diabetes Mellitus, Type 2 — fewer than ten, so there is no comparison to draw.
4 of the studies in Diabetes Mellitus, Type 2 with a site in Malaysia that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07877948BREGO Life SciencesComparative Study of Combination Treatment of Bionerv E+ Versus Vitamin B Complex in Treatment of Diabetic Polyneuropathy in Type 2 Diabetic Patients and Its Effect on Wound Healing | 2027-01-30 |
| NCT07532863Novo Nordisk A/SA Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Participants | 2027-03-27 |
| NCT07606066AstraZenecaA Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies | 2027-03-31 |
| NCT07664501Universiti Teknologi MaraThe Simplified Total-body Resistance Exercise for Muscular Hypertrophy for Diabetic Population (D-STORM) | 2027-09-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 170 studies in Diabetes Mellitus, Type 2 with a site in Malaysia, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to learn if sending three (3) text messages per week over a six (6) months period to people with Type 2 Diabetes in areas with lack access to dietitian could help them stick to a healthier diet. The main questions it aims to answer are:
Participants will:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
HbA1c
A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants from control groups will receive the usual care, which will be a three-monthly nutrition consultation by a visiting dietitian
Other: Control Group
Participants from the intervention group will receive the usual care and an additional three text messages per week via WhatsApp over the 6-month intervention period
Other: Intervention Group
Participants from the intervention group will receive the usual care over the 6-month intervention period
Participants from the intervention group will receive the usual care and an additional three text messages per week via WhatsApp over the 6-month intervention period
Comparison of dietary adherence at 3-month and 6-month between the usual care group and intervention group
Dietary adherence to diabetic diet will be evaluated against a modified healthy eating index (HEI). A 3-day dietary record methodology (2 weekdays and 1 weekend) will be used and analyzed based on Malaysian and Singapore Food Composition Databases. The modified version of HEI used in this study consists of 14 components. Sum scores of each component yields and overall score of diet quality which will be converted into scale of zero to 100. A higher the HEI score indicates a greater adherence. The overall dietary adherence will be classified as low (below 51%), needing improvement (51-80%), or high (more than 80 points)
Time frame: Baseline, 3-month, and 6-month
Comparison of glycated hemoglobin (HbA1c) at 3-month and 6-month between the usual care group and intervention group
Change in HbA1c will be determined by blood test at baseline, 3 and 6 months. The HbA1c result will be retrieved from the participants' routine blood result at health clinic or hospital, which will be analyzed following a standardized analytic protocol of Ministry of Health, Malaysia
Time frame: Baseline, 3-month, and 6-month
Comparison of self-management behavior at 3-month and 6-month between the usual care group and intervention group
The Malay version of the Summary of Diabetes Self-Care Activities (SDSCA) will be used to measure diabetes self-management activities. The SDSCA will be used to examine the participants' compliance in performing five main self-care activities. The degree of compliance or frequency with which the person engages in each self-care behavior is considered when interpreting the SDSCA scores. Higher ratings across the board typically suggest better adherence and more active diabetes self-management.
Time frame: Baseline, 3-month, and 6-month
Plan to share: No
Start is estimated for Jan 2025; primary completion for Jul 2025, 6 months later.
Of 2,078 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 6 months is below that.
Counting every sponsor, half of 2,255 studies reached it within 21 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universiti Malaysia Sabah